| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |